Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

191622-103 BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Adolescents (Children 12 to < 18 Years of Age) With Chronic Migraine

NCT01662492 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01662492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01662492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
191622-103 BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Adolescents (Children 12 to < 18 Years of Age) With Chronic Migraine
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2012
Completion date
August 31, 2016
Enrollment
125 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disorders